NEW
Stock Screener with Intrinsic Value
Summit Therapeutics Inc. (SMMT)
Last Price$19.04.6%
Market Cap$13.8B
($235.0K)
N/A
($196.7M)
-88.0% YoY
($454.4M)
Net Debt to FCF - 4.0x
($112.9M)
48,028.4% margin
SMMT Income Statement
SMMT Income Statement Overview
Crunching data... Almost there!
SMMT Income statement key metrics
Crunching data... Almost there!
SMMT Balance Sheet
SMMT Balance Sheet Overview
Crunching data... Almost there!
SMMT Balance Sheet Metrics
Crunching data... Almost there!
SMMT Cash Flow Statement
SMMT Cash Flow Statement Overview
Crunching data... Almost there!
SMMT Cash Flow Statement key metrics
Crunching data... Almost there!
SMMT Financials
Crunching data... Almost there!
FAQ
What is the Summit Therapeutics Inc. (SMMT) revenue?
The Summit Therapeutics Inc. (SMMT) revenue is $0.0, reflecting a year-over-year (YoY) growth of -100.0% YoY.
What is the Summit Therapeutics Inc. (SMMT) Net Income?
The Summit Therapeutics Inc. (SMMT) Net Income is ($614.9M), showcasing a YoY growth of +726.7% YoY.
What is Summit Therapeutics Inc. (SMMT) net debt?
What is the Summit Therapeutics Inc. (SMMT) Free Cash Flow (FCF)?
The Summit Therapeutics Inc. (SMMT) Free Cash Flow (FCF) stands at ($76.9M), accounting for a N/A margin.